PAG
BMY.RT

Private Advisor Group’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Private Advisor Group’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-147,024
Closed -$101K – 2002
2020
Q4 		$101K Sell
147,024
-3,916
-3% -$8.34K ﹤0.01% 1689
2020
Q3 		$479K Sell
150,940
-9,135
-6% -$26.1K 0.01% 1070
2020
Q2 		$573K Buy
160,075
+447
+0.3% +$1.61K 0.01% 966
2020
Q1 		$606K Sell
159,628
-702
-0.4% -$2.31K 0.01% 827
2019
Q4 		$483K Buy
+160,330
New +$417K 0.01% 1058

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Private Advisor Group's BMY.RT Position: Q1 2021 in Review

Private Advisor Group sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 147,024 shares — an estimated $101K sold.

Private Advisor Group first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $606K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Private Advisor Group reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Private Advisor Group sold 147,024 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $101K.
  • Private Advisor Group first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Private Advisor Group's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $606K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Private Advisor Group's 13F filing for Q1 2021, filed 22 Apr 2021.